BioSpace News Archive

Business

BioArctic Interim Report January – June 2019

BioArctic received MEUR 15 milestone payment from Eisai for start of BAN2401 confirmatory Phase 3 study in early Alzheimer’s disease

July 11, 2019
·
7 min read
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research

Novotech, the award-winning Asia-Pacific CRO, has further strengthened its presence in the region through a Partnership with the Skin Research Institute of Singapore.

July 11, 2019
·
1 min read
Deals

vasopharm Closes €9.5 million Financing Round

vasopharm GmbH, a private biopharmaceutical company developing a novel treatment for traumatic brain injury, announced the successful completion of a €9.5 million financing co-led by HeidelbergCapital Private Equity and EF Investments.

July 11, 2019
·
5 min read
Paving the road to paradigm changing therapies with the next generation TLR9 agonist immunotherapy platform

Setting our strategic vision for the next generation TLR9 immunotherapy platform – introducing MOLOGEN’s new CEO Dr. Stefan M. Manth

July 11, 2019
·
3 min read
Top dementia experts identify gaps holding back potential treatments

Leading dementia figures from universities, pharmaceutical companies and charities have identified six gaps in dementia research that present new opportunities to speed up the search for the first life-changing treatment for the condition.

July 11, 2019
·
5 min read
Policy

Dementia included in new £135m NIHR research funding

The National Institute of Health Research has announced £135m of funding for new research projects across the UK to tackle some of the biggest health conditions, including dementia.

July 11, 2019
·
1 min read
Business

BioSpace Movers and Shakers, July 12

Biotech and pharma companies strengthen their leadership teams with new appointments.

July 11, 2019
·
5 min read
·
Alex Keown
Business

Allergy Therapeutics plc Trading update

Allergy Therapeutics plc provides a trading update for the year ended 30 June 2019 ahead of its Preliminary Results to be announced on 25 September 2019.

July 11, 2019
·
3 min read
Policy

EU Healthcare Systems: A Reallocation of Resources is Urgently Needed

Turning away from “low-value” (waste, overuse) towards “high-value” health care is critical for the sustainability of solidarity-based healthcare systems. The Ludwig Boltzmann Institute for Health Technology Assessment is represented on the European Expert Panel.

July 11, 2019
·
4 min read
Drug Development

Prescient Therapeutics Initiates Phase 1b Clinical Trial for First-in Class Anti-Cancer Drug PTX-100 in Patients with Multiple Cancers

Prescient Therapeutics Limited, a clinical stage oncology company, announced the start of a Phase 1b trial of its second targeted anti-cancer drug PTX-100 in Australia.

July 11, 2019
·
6 min read